Measurable Residual Disease in Acute Myeloid Leukemia Using Flow Cytometry: A Review of Where We Are and Where We Are Going

by Caroline Dix, Tsun-Ho Lo, Georgina Clark, Edward Abadir
Published 2020-06-01

Is Hematopoietic Stem Cell Transplantation Required to Unleash the Full Potential of Immunotherapy in Acute Myeloid Leukemia?

by Edward Abadir, Robin E. Gasiorowski, Pablo A. Silveira, Stephen Larsen, Georgina J. Clark
Published 2020-02-01

CD83: Activation Marker for Antigen Presenting Cells and Its Therapeutic Potential

by Ziduo Li, Ziduo Li, Xinsheng Ju, Xinsheng Ju, Pablo A. Silveira, Pablo A. Silveira, Edward Abadir, Edward Abadir, Wei-Hsun Hsu, Wei-Hsun Hsu, Derek N. J. Hart, Derek N. J. Hart, Georgina J. Clark, Georgina J. Clark
Published 2019-06-01

Targeting CD83 in mantle cell lymphoma with anti‐human CD83 antibody

by Ziduo Li, Edward Abadir, Kenneth Lee, Candice Clarke, Christian E Bryant, Wendy Cooper, Geoffrey Pietersz, James Favaloro, Pablo A Silveira, Derek NJ Hart, Xinsheng Ju, Georgina J Clark
Published 2020-01-01

Examination of CD302 as a potential therapeutic target for acute myeloid leukemia.

by Tsun-Ho Lo, Edward Abadir, Robin E Gasiorowski, Karieshma Kabani, Murari Ramesh, Daniel Orellana, Phillip D Fromm, Fiona Kupresanin, Elizabeth Newman, Ilona Cunningham, Derek N J Hart, Pablo A Silveira, Georgina J Clark
Published 2019-01-01

CD300f epitopes are specific targets for acute myeloid leukemia with monocytic differentiation

by Edward Abadir, Robin E. Gasiorowski, Kaitao Lai, Fiona Kupresanin, Adelina Romano, Pablo A. Silveira, Tsun‐Ho Lo, Phillip D. Fromm, Marina L. Kennerson, Harry J. Iland, P. Joy Ho, P. Mark Hogarth, Kenneth Bradstock, Derek N.J. Hart, Georgina J. Clark
Published 2019-10-01